A finding of note from our present study is the lack of association between plasma galectin-3 concentrations, and the presence of derangements such as arterial hypertension, diabetes, dyslipidemia, ischemic heart disease, or chronic obstructive pulmonary disease. This evidence concerns the gene LGALS3 and coronary artery disorder.